EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Preventing Contrast-Induced Acute Kidney Injury in Egyptian Patients Undergoing Coronary Angiography: A Randomized Controlled Trial

Sarah Sabry, Mai K Ammar, Mahmoud Taeima, Noha Nassar, Azza ElFiky, Ayman Saleh

Clinical Drug Investigation · 2026

DOI: 10.1007/s40261-026-01524-4 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Drug Investigation, 2026. Verfasst von Sarah Sabry und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Cardiovascular Hospital, Ain Shams University, 110 Ibn Fadlan Street, Nasr City, Cairo, Egypt. ssabry@ecu.edu.eg. Hauptthemen laut MEDLINE: Acetylcysteine, Acute Kidney Injury, Contrast Media, Coronary Angiography. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Egyptian Chinese University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVES: Contrast-induced acute kidney injury (CI-AKI) observed after coronary angiography (CAG) requires preventive strategies guided by clinical judgment. Evidence is still lacking regarding the prevention of CI-AKI in patients undergoing coronary angiography. This study aimed to compare the effect of a high dose of N-acetylcysteine (NAC) plus preprocedural hydration, a high dose of atorvastatin (HDS) plus preprocedural hydration, or preprocedural hydration alone on the prevention of CI-AKI in patients undergoing elective coronary angiography. METHODS: A prospective multi-armed randomized comparative study was conducted on elective patients undergoing CAG. Patients were randomly assigned to either control group [n = 40], who received hydration with 0.9% saline started just before contrast media injection and continued for 12 h at a rate 1.0 mL/kg/min after angiography; NAC group [n = 40], who received oral NAC 1200 mg daily started 5 days before angiography and good hydration; or HDS group [n = 40], receiving one oral dose of atorvastatin 80 mg 24 h before angiography and good hydration. CI-AKI was defined as an increase in serum creatinine of > 25% of baseline or an absolute increase of 0.5 mg/dL above baseline after 48 h. Incidence of CI-AKI and incidence of complications were assessed for all groups. RESULTS: The study included 120 patients. The incidence of CI-AKI was [32.5%] in the control group, [20%] in the NAC group, and [12.5%] in the HDS group. The incidence of CI-AKI was significantly lower in the high-dose statin group compared with the control group (risk ratio = 1.658; 95% CI 1.050-2.433). In-hospital clinical outcomes showed no statistical significance among the three groups. CONCLUSIONS: Both NAC and high-dose statins may reduce CI-AKI incidence in patients undergoing CAG, with statins showing more promising results. These findings support prophylactic strategies for CI-AKI prevention in high-risk patients undergoing CAG. In-hospital outcomes were comparable. CLINICAL TRIAL REGISTRATION: Clinical-Trials.gov (ID; NCT06139952, Date; December 2023).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineAcute Kidney InjuryContrast MediaCoronary AngiographyAgedFemaleHumansMaleMiddle AgedAtorvastatinCreatinineEgyptFluid TherapyHydroxymethylglutaryl-CoA Reductase InhibitorsProspective Studies

Substanzen

AcetylcysteineAtorvastatinContrast MediaCreatinineHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • The Cardiovascular Hospital, Ain Shams University, 110 Ibn Fadlan Street, Nasr City, Cairo, Egypt. ssabry@ecu.edu.eg.
  • Department of Pharmacy Practice, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, Cairo, Egypt. ssabry@ecu.edu.eg.
  • Department of Pharmacognosy, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, Cairo, Egypt.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology, Faculty of Pharmacy, October University for Modern Sciences and Arts, Giza, Egypt.

Förderung

  • Egyptian Chinese University

Zitieren

APA

Sabry, S., Ammar, M. K., Taeima, M., Nassar, N., ElFiky, A., & Saleh, A. (2026). Preventing Contrast-Induced Acute Kidney Injury in Egyptian Patients Undergoing Coronary Angiography: A Randomized Controlled Trial. Clinical Drug Investigation. https://doi.org/10.1007/s40261-026-01524-4

Vancouver

Sabry S, Ammar MK, Taeima M, Nassar N, ElFiky A, Saleh A. Preventing Contrast-Induced Acute Kidney Injury in Egyptian Patients Undergoing Coronary Angiography: A Randomized Controlled Trial. Clinical Drug Investigation. 2026. doi:10.1007/s40261-026-01524-4

BibTeX
@article{Sabry2026,
  author = {Sabry, Sarah and Ammar, Mai K and Taeima, Mahmoud and Nassar, Noha and ElFiky, Azza and Saleh, Ayman},
  title = {Preventing Contrast-Induced Acute Kidney Injury in Egyptian Patients Undergoing Coronary Angiography: A Randomized Controlled Trial},
  journal = {Clinical Drug Investigation},
  year = {2026},
  doi = {10.1007/s40261-026-01524-4}
}
Kostenlos starten →